Cited by 1,518Neuroscience and Neuropharmacology ResearchAmino Acid Enzymes and MetabolismNeuroprotection in Cerebral Ischemia

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression

Rothstein, Jeffrey D., Patel, Sarjubhai, Regan, Melissa R., Haenggeli, Christine, Huang, Yanhua H., Bergles, Dwight E., Jin, Lin, Dykes Hoberg, Margaret, Vidensky, Svetlana, Chung, Dorothy S., Toan, Shuy Vang, Bruijn, Lucie I., Su, Zao-zhong, Gupta, Pankaj, Fisher, Paul B.·2005·Nature

DOI 10.1038/nature03180

Open this paper in CoChat — free account

Abstract

Glutamate is the principal excitatory neurotransmitter in the nervous system. Inactivation of synaptic glutamate is handled by the glutamate transporter GLT1 (also known as EAAT2; refs 1, 2), the physiologically dominant astroglial protein. In spite of its critical importance in normal and abnormal synaptic activity, no practical pharmaceutical can positively modulate this protein. Animal studies show that the protein is important for normal excitatory synaptic transmission, while its dysfunction is implicated in acute and chronic neurological disorders, including amyotrophic lateral sclerosis (ALS), stroke, brain tumours and epilepsy. Using a blinded screen of 1,040 FDA-approved drugs and nutritionals, we discovered that many beta-lactam antibiotics are potent stimulators of GLT1 expression. Furthermore, this action appears to be mediated through increased transcription of the GLT1 gene. beta-Lactams and various semi-synthetic derivatives are potent antibiotics that act to inhibit bacterial synthetic pathways. When delivered to animals, the beta-lactam ceftriaxone increased both brain expression of GLT1 and its biochemical and functional activity. Glutamate transporters are important in preventing glutamate neurotoxicity. Ceftriaxone was neuroprotective in vitro when used in models of ischaemic injury and motor neuron degeneration, both based in part on glutamate toxicity. When used in an animal model of the fatal disease ALS, the drug delayed loss of neurons and muscle strength, and increased mouse survival. Thus these studies provide a class of potential neurotherapeutics that act to modulate the expression of glutamate neurotransmitter transporters via gene activation.

Integrity signals

Registry

Crossref · 10.1038/nature03180

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,796
Glutamate uptake
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate
Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80086-0 · Cited by 2,534
Self-citation
Epilepsy and Exacerbation of Brain Injury in Mice Lacking the Glutamate Transporter GLT-1
Tanaka, K., Watase, K., Manabe, T., Yamada, K., Watanabe, M., Takahashi, K., Iwama, H., Nishikawa, T., Ichihara, N., Kikuchi, T., et al. (1997) · Science · doi:10.1126/science.276.5319.1699 · Cited by 1,755
Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis
Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J., & Kuncl, R. W. (1995) · Annals of Neurology · doi:10.1002/ana.410380114 · Cited by 1,471
Self-citation
Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis
Rothstein, J. D., Martin, L. J., & Kuncl, R. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205283262204 · Cited by 1,197
Self-citation
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)
Howland, D., Liu, J., She, Y., Goad, B., Maragakis, N. J., Kim, B. B., Erickson, J., Kulik, J., DeVito, L., Psaltis, G. C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032539299 · Cited by 890
Self-citation
Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model
Kaspar, B. K., Lladó, J., Sherkat, N., Rothstein, J. D., & Gage, F. H. (2003) · Science · doi:10.1126/science.1086137 · Cited by 872
Self-citation
Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity.
Rothstein, J. D., Jin, L., Dykes‐Hoberg, M., & Kuncl, R. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6591 · Cited by 623
Self-citation

Flagged first, then by citations

Show all 27 references

Sorted by citations

Items 201–300 of 1,000

Caspase-3 Cleaves and Inactivates the Glutamate Transporter EAAT2
Boston-Howes, W., Gibb, S. L., Williams, E. O., Pasinelli, P., Brown, R. H., & Trotti, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600653200 · Cited by 141
Clinical Consequences of Infection in Patients With Acute Stroke
Vargas, M., Horcajada, J. P., Obach, V., Revilla, M., Cervera, Á., Torres, F., Planas, A. M., Mensa, J., & Chamorro, Á. (2005) · Stroke · doi:10.1161/01.str.0000199138.73365.b3 · Cited by 137
Thiamine Deficiency: An Update of Pathophysiologic Mechanisms and Future Therapeutic Considerations
Abdou, E., & Hazell, A. S. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1430-z · Cited by 139
Oxidative stress during the chronic phase after stroke
Alexandrova, M. L., & Bochev, P. G. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.04.017 · Cited by 135
Astrogliosis in Amyotrophic Lateral Sclerosis: Role and Therapeutic Potential of Astrocytes
Vargas, M. R., & Johnson, J. A. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.012 · Cited by 145
A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis
Pascuzzi, R. M., Shefner, J. M., Chappell, A. S., Bjerke, J. S., Tamura, R., Chaudhry, V., Clawson, L., Haas, L., & Rothstein, J. D. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960903307805 · Cited by 134
Self-citation
Ceftriaxone Normalizes Nucleus Accumbens Synaptic Transmission, Glutamate Transport, and Export following Cocaine Self-Administration and Extinction Training
Trantham‐Davidson, H., LaLumiere, R. T., Reissner, K. J., Kalivas, P. W., & Knackstedt, L. A. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1976-12.2012 · Cited by 138
Ischemic Preconditioning Reveals that GLT1/EAAT2 Glutamate Transporter is a Novel PPARγ Target Gene Involved in Neuroprotection
Romera, C., Hurtado, O., Mallolas, J., Pereira, M. P., Morales, J. R., Romera, A., Serena, J. L., Vivancos, J., Nombela, F., Lorenzo, P. L., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600438 · Cited by 135
Microglia as a Pharmacological Target in Infectious and Inflammatory Diseases of the Brain
Rock, R. B., & Peterson, P. K. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9012-8 · Cited by 130
Impaired Glutamate Transport in a Mouse Model of Tau Pathology in Astrocytes
Dabir, D. V., Robinson, M. B., Swanson, E., Zhang, B., Trojanowski, J. Q., Lee, V. M. ‐., & Forman, M. S. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3861-05.2006 · Cited by 138
SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments
Joyce, P. I., Fratta, P., Fisher, E., & Acevedo‐Arozena, A. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9339-1 · Cited by 139
Glutamate Clearance Is Locally Modulated by Presynaptic Neuronal Activity in the Cerebral Cortex
Armbruster, M., Hanson, E., & Dulla, C. G. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2066-16.2016 · Cited by 131
Reactive Astrocytes Promote ALS-like Degeneration and Intracellular Protein Aggregation in Human Motor Neurons by Disrupting Autophagy through TGF-β1
Tripathi, P., Rodriguez-Muela, N., Klim, J. R., de Boer, A. S., Agrawal, S., Sandoe, J., Lopes, C. S., Ogliari, K. S., Williams, L. A., Shear, M., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.06.008 · Cited by 123
Targets for future clinical trials in Huntington's disease: What's in the pipeline?
Wild, E. J., & Tabrizi, S. J. (2014) · Movement Disorders · doi:10.1002/mds.26007 · Cited by 135
Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT‐1/EAAT2 subtype
Li, L., Toan, S. V., Zelenaia, O. A., Watson, D. J., Wolfe, J. H. N., Rothstein, J. D., & Robinson, M. B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03743.x · Cited by 133
Self-citation
Do Reaction Conditions Affect the Stereoselectivity in the Staudinger Reaction?
Wang, Y., Liang, Y. F., Jiao, L., Du, D., & Xu, J. (2006) · The Journal of Organic Chemistry · doi:10.1021/jo0611521 · Cited by 129
Amyotrophic Lateral Sclerosis
Gordon, P. H. (2010) · CNS Drugs · doi:10.2165/11586000-000000000-00000 · Cited by 140
The Tau/A152T mutation, a risk factor for frontotemporal‐spectrum disorders, leads to NR2B receptor‐mediated excitotoxicity
Decker, J. M., Krüger, L., Sydow, A., Dennissen, F. J. A., Šišková, Z., Mandelkow�, E., & Mandelkow, E. (2016) · EMBO Reports · doi:10.15252/embr.201541439 · Cited by 130
The Concise Guide to PHARMACOLOGY 2013/14: Transporters
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12450 · Cited by 126
The inflammatory cytokine, interleukin‐1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitis
Prow, N. A., & Irani, D. N. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05230.x · Cited by 126
Rodent models of TDP-43: Recent advances
Tsao, W., Jeong, Y. H., Lin, S. Z., Ling, J. P., Price, D. L., Chiang, P., & Wong, P. C. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.031 · Cited by 129
Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring rats
Das, S. C., Yamamoto, B. K., Hristov, A. M., & Sari, Y. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.05.009 · Cited by 125
Regulation and Dysregulation of Glutamate Transporters
Sattler, R., & Rothstein, J. D. (2006) · Springer eBooks · doi:10.1007/3-540-29784-7_14 · Cited by 127
Self-citation
Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex
Zeng, L., Ouyang, Y., Gazit, V. A., Cirrito, J. R., Jansen, L. A., Ess, K. C., Yamada, K. A., Wozniak, D. F., Holtzman, D. M., Gutmann, D. H., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.015 · Cited by 122
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
Tefera, T. W., Steyn, F. J., Ngo, S. T., & Borges, K. (2021) · Cell & Bioscience · doi:10.1186/s13578-020-00511-2 · Cited by 122
Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1G93A mice
Pardo, A. C., Wong, V., Benson, L. M., Dykes, M., Tanaka, K., Rothstein, J. D., & Maragakis, N. J. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.03.028 · Cited by 122
Self-citation
Glutamate transporters in the biology of malignant gliomas
Robert, S. M., & Sontheimer, H. W. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1521-z · Cited by 123
Inhibitors of Cytochrome c Release with Therapeutic Potential for Huntington's Disease
Wang, X., Zhu, S., Pei, Z., Drozda, M., Stavrovskaya, I. G., Signore, S. J. D., Cormier, K., Shimony, E. M., Wang, H., Ferrante, R. J., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1867-08.2008 · Cited by 120
Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment
Goodall, G., & Morrison, K. E. (2006) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399406010854 · Cited by 119
Riluzole elevates GLT-1 activity and levels in striatal astrocytes
Carbone, M., Duty, S., & Rattray, M. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.10.017 · Cited by 117
Glutamate-Based Antidepressants: Preclinical Psychopharmacology
Pilc, A., Wierońska, J. M., & Skolnick, P. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.021 · Cited by 119
SLC1 glutamate transporters
Grewer, C. T., Gameiro, A. M., & Rauen, T. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1397-7 · Cited by 115
Depressogenic effects of medications: a review
Celano, C. M., Freudenreich, O., Fernandez-Robles, C. G., Stern, T. A., Caro, M. A., & Huffman, J. C. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/ccelano · Cited by 118
Astrocytic function and its alteration in the epileptic brain
Jabs, R., Seifert, G., & Steinhäuser, C. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01488.x · Cited by 130
The β-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke
Thöne‐Reineke, C., Neumann, C., Namsolleck, P., Schmerbach, K., Krikov, M., Schefe, J. H., Lucht, K., Hörtnagl, H., Godes, M., Müller, S., et al. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328313e403 · Cited by 115
Pharmacological evaluation of glutamate transporter 1 (GLT-1) mediated neuroprotection following cerebral ischemia/reperfusion injury
Verma, R., Mishra, V., Sasmal, D., & Raghubir, R. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.04.021 · Cited by 115
Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease
Vucic, S., & Kiernan, M. C. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0487-6 · Cited by 120
Astrocytes as a Therapeutic Target in Alzheimer’s Disease–Comprehensive Review and Recent Developments
Rodríguez-Giraldo, M., González-Reyes, R. E., Ramírez-Guerrero, S., Bonilla-Trilleras, C. E., Guardo-Maya, S., & Nava-Mesa, M. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113630 · Cited by 122
Identification of FDA-Approved Drugs and Bioactives that Protect Hair Cells in the Zebrafish (Danio rerio) Lateral Line and Mouse (Mus musculus) Utricle
Ou, H. C., Cunningham, L. L., Francis, S. P., Brandon, C. S., Simon, J. A., Raible, D. W., & Rubel, E. W. (2009) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-009-0158-y · Cited by 114
Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders
Ramos, K. M., Lewis, M. T., Morgan, K. N., Crysdale, N. Y., Kroll, J. L., Taylor, F. R., Harrison, J. A., Sloane, E. M., Maier, S. F., & Watkins, L. R. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.06.014 · Cited by 114
Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration
Garden, G. A., & Spada, A. R. L. (2008) · The Cerebellum · doi:10.1007/s12311-008-0027-y · Cited by 116
Aquaporin-4 Deficiency Impairs Synaptic Plasticity and Associative Fear Memory in the Lateral Amygdala: Involvement of Downregulation of Glutamate Transporter-1 Expression
Li, Y., Wang, F., Wang, W., Luo, Y., Wu, P.-F., Xiao, J., Hu, Z., Jin, Y., Hu, G., & Chen, J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.34 · Cited by 114
Histone Deacetylase Inhibitors Preserve White Matter Structure and Function during Ischemia by Conserving ATP and Reducing Excitotoxicity
Baltan, S., Murphy, S. P., Danilov, C. A., Bachleda, A., & Morrison, R. S. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5379-10.2011 · Cited by 111
Multimodal Actions of Neural Stem Cells in a Mouse Model of ALS: A Meta-Analysis
Teng, Y. D., Benn, S. C., Kalkanis, S. N., Shefner, J. M., Onario, R. C., Cheng, B., Lachyankar, M. B., Marconi, M., Li, J., Yu, D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004579 · Cited by 112
Self-citation
Oncogene AEG-1 Promotes Glioma-Induced Neurodegeneration by Increasing Glutamate Excitotoxicity
Lee, S., Kim, K., Kegelman, T. P., Dash, R., Das, S. K., Choi, J. K., Emdad, L., Howlett, E. L., Jeon, H. Y., Su, Z. Z., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0782 · Cited by 110
Self-citation
Toxoplasmosis: A pathway to neuropsychiatric disorders
Tyebji, S., Seizova, S., Hannan, A. J., & Tonkin, C. J. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.11.012 · Cited by 112
Emerging targets and treatments in amyotrophic lateral sclerosis
Zinman, L. H., & Cudkowicz, M. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70024-2 · Cited by 111
Neural Stem Cell Transplantation Induces Stroke Recovery by Upregulating Glutamate Transporter GLT-1 in Astrocytes
Bacigaluppi, M., Russo, G. L., Peruzzotti‐Jametti, L., Rossi, S., Sandrone, S., Butti, E., Ceglia, R. D., Bergamaschi, A., Motta, C., Gallizioli, M., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1643-16.2016 · Cited by 109
Targeted Over-Expression of Glutamate Transporter 1 (GLT-1) Reduces Ischemic Brain Injury in a Rat Model of Stroke
Harvey, B. K., Airavaara, M., Hinzman, J. M., Wires, E. M., Chiocco, M. J., Howard, D. B., Shen, H., Gerhardt, G. A., Hoffer, B. J., & Wang, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022135 · Cited by 108
Modeling neurodegenerative disease pathophysiology in thiamine deficiency: Consequences of impaired oxidative metabolism
Jhala, S. S., & Hazell, A. S. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.11.019 · Cited by 109
Astroglia as a cellular target for neuroprotection and treatment of neuro‐psychiatric disorders
Liu, B., Teschemacher, A. G., & Kasparov, S. (2017) · Glia · doi:10.1002/glia.23136 · Cited by 111
Oxidative Stress and Neuroinflammation as a Pivot in Drug Abuse. A Focus on the Therapeutic Potential of Antioxidant and Anti-Inflammatory Agents and Biomolecules
Berríos‐Cárcamo, P., Quezada, M., Quintanilla, M. E., Morales, P., Ezquer, M., Herrera‐Marschitz, M., Israel, Y., & Ezquer, F. E. (2020) · Antioxidants · doi:10.3390/antiox9090830 · Cited by 115
Cardiac glycosides provide neuroprotection against ischemic stroke: Discovery by a brain slice-based compound screening platform
Wang, J. K. T., Portbury, S. D., Thomas, M. B., Barney, S., Ricca, D. J., Morris, D. L., Warner, D. S., & Lo, D. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600930103 · Cited by 109
Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease
Huang, K., Kang, M. H., Askew, C. E., Kang, R., Sanders, S. S., Wan, J., Davis, N. G., & Hayden, M. R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.027 · Cited by 107
The Role of Astrocytic Aquaporin-4 in Synaptic Plasticity and Learning and Memory
Szu, J. I., & Binder, D. K. (2016) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2016.00008 · Cited by 117
Astrocyte–neuron interplay in maladaptive plasticity.
Papa, M., De Luca, C., Petta, F., Alberghina, L., & Cirillo, G. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.01.010 · Cited by 104
Design and Initial Results of a Multi-Phase Randomized Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis
Berry, J. D., Shefner, J. M., CONWIT, R. A., Schoenfeld, D., Keroack, M. D., Felsenstein, D., Krivickas, L. S., David, W. S., Vriesendorp, F. J., Pestronk, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061177 · Cited by 106
Self-citation
Mutant TDP-43 in motor neurons promotes the onset and progression of ALS in rats
Huang, C., Tong, J., Bi, F., Zhou, H., & Xia, X. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59130 · Cited by 108
Selective deletion of astroglial FMRP dysregulates glutamate transporter GLT1 and contributes to fragile X syndrome phenotypes in vivo.
Higashimori, H., Schin, C. S., Chiang, M. S. R., Morel, L., Shoneye, T. A., Nelson, D. L., & Yang, Y. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1069-16.2016 · Cited by 105
Tetracycline repurposing in neurodegeneration: focus on Parkinson’s disease
Bortolanza, M., Nascimento, G. C., Socías, S. B., Ploper, D., Chehín, R. N., Raisman‐Vozari, R., & Bel, E. A. D. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1913-1 · Cited by 104
Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6‐hydroxydopamine‐lesioned rats
Chung, E. K. Y., Chen, L. W., Chan, Y., & Yung, K. K. L. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21852 · Cited by 105
Neurological Adverse Effects Attributable to β-Lactam Antibiotics: A Literature Review
Deshayes, S., Coquerel, A., & Verdon, R. (2017) · Drug Safety · doi:10.1007/s40264-017-0578-2 · Cited by 104
Main path and byways: non‐vesicular glutamate release by system xc−as an important modifier of glutamatergic neurotransmission
Massie, A., Boillée, S., Hewett, S. J., Knackstedt, L. A., & Lewerenz, J. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13348 · Cited by 106
Roles of glutamate signaling in preclinical and/or mechanistic models of depression
Tokita, K., Yamaji, T., & Hashimoto, K. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.016 · Cited by 104
Cortical Dysfunction Underlies the Development of the Split-Hand in Amyotrophic Lateral Sclerosis
Menon, P., Kiernan, M. C., & Vucic, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087124 · Cited by 103
Altered Functionality, Morphology, and Vesicular Glutamate Transporter Expression of Cortical Motor Neurons from a Presymptomatic Mouse Model of Amyotrophic Lateral Sclerosis
Saba, L., Viscomi, M. T., Caioli, S., Pignataro, A., Bisicchia, E., Pieri, M., Molinari, M., Ammassari‐Teule, M., & Zona, C. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhu317 · Cited by 110
Yin Yang 1 Is a Repressor of Glutamate Transporter EAAT2, and It Mediates Manganese-Induced Decrease of EAAT2 Expression in Astrocytes
Karki, P., Webb, A., Smith, K., Johnson, J., Lee, K., Son, D., Aschner, M., & Lee, E.-S. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01176-13 · Cited by 103
Neuron–astrocyte communication and synaptic plasticity
Paixão, S., & Klein, R. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.04.008 · Cited by 106
Neuromyelitis optica: Aquaporin-4 based pathogenesis mechanisms and new therapies
Ratelade, J., & Verkman, A. S. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.06.013 · Cited by 102
Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis
Boucherie, C., Schäfer, S., Lavand'homme, P. M., Maloteaux, J., & Hermans, E. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22038 · Cited by 100
Final Report of the Lyme Disease Review Panel of the Infectious Diseases Society of America
Lantos, P. M., Charini, W. A., Medoff, G., Moro, M. H., Mushatt, D. M., Parsonnet, J., Sanders, J. W., & Baker, C. J. (2010) · Clinical Infectious Diseases · doi:10.1086/654809 · Cited by 102
Expression Profiling of the Solute Carrier (SLC) Gene Family in the Mouse Brain
Dahlin, A., Royall, J., Hohmann, J., & Wang, J. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.149831 · Cited by 102
Copper mediated neurological disorder: Visions into amyotrophic lateral sclerosis, Alzheimer and Menkes disease
Ahuja, A., Dev, K., Tanwar, R. S., Selwal, K. K., & Tyagi, P. K. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.05.003 · Cited by 103
TNF-α potentiates glutamate-induced spinal cord motoneuron death via NF-κB
Tolosa, L., Caraballo-Miralles, V., Olmos, G., & Lladó, J. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.09.001 · Cited by 98
Disruptions in the Regulation of Extracellular Glutamate by Neurons and Glia in the Rat Striatum Two Days after Diffuse Brain Injury
Hinzman, J. M., Thomas, T. C., Quintero, J. E., Gerhardt, G. A., & Lifshitz, J. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2011.2261 · Cited by 101
Molecular and cellular physiology of sodium-dependent glutamate transporters
Rose, C. R., Ziemens, D., Untiet, V., & Fahlke, C. M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.12.013 · Cited by 100
EAAT2 regulation and splicing: relevance to psychiatric and neurological disorders
Lauriat, T. L., & McInnes, L. A. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002065 · Cited by 102
Up‐regulation of GLT‐1 severely impairs LTD at mossy fibre–CA3 synapses
Omrani, A., Melone, M., Bellesi, M., Safiulina, V. F., Aida, T., Tanaka, K., Cherubini, E., & Conti, F. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.177881 · Cited by 99
The wobbler mouse, an ALS animal model
Moser, J., Bigini, P., & Schmitt‐John, T. (2013) · Molecular Genetics and Genomics · doi:10.1007/s00438-013-0741-0 · Cited by 108
Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?
Klein, P., Friedman, A., Hameed, M. Q., Kaminski, R. M., Bar‐Klein, G., Klitgaard, H., Koepp, M. J., Jóźwiak, S., Prince, D. A., Rotenberg, A., et al. (2020) · Epilepsia · doi:10.1111/epi.16450 · Cited by 100
Selective up-regulation of the glial Na+-dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in neuroprotection
Ganel, R., Ho, T. W., Maragakis, N. J., Jackson, M. T., Steiner, J. P., & Rothstein, J. D. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.014 · Cited by 98
Self-citation
Spinal Muscular Atrophy: From Gene Discovery to Clinical Trials
Nurputra, D. K., Lai, P. S., Harahap, N. I. F., Morikawa, S., Yamamoto, T., Nishimura, N., Kubo, Y., Takeuchi, A., Saito, T., Takeshima, Y., et al. (2013) · Annals of Human Genetics · doi:10.1111/ahg.12031 · Cited by 97
Drug screening for hearing loss: Using the zebrafish lateral line to screen for drugs that prevent and cause hearing loss
Ou, H. C., dos Santos, F. O., Raible, D. W., Simon, J. A., & Rubel, E. W. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.01.001 · Cited by 97
Ceftriaxone Treatment Affects the Levels of GLT1 and ENT1 As Well As Ethanol Intake in Alcohol-Preferring Rats
Sari, Y., Sreemantula, S. N., Lee, M. R., & Choi, D. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0064-y · Cited by 96
An anti-nociceptive role for ceftriaxone in chronic neuropathic pain in rats
Hu, Y., Li, W., Lu, L., Cai, J., Xian, X., Zhang, M., Li, Q., & Li, L. (2009) · Pain · doi:10.1016/j.pain.2009.11.014 · Cited by 96
Neuroprotective Effect of Ceftriaxone on MPTP‐Induced Parkinson’s Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota
Zhou, X., Lu, J., Wei, K., Wei, J., Tian, P., Yue, M., Wang, Y., Hong, D., Li, F., Wang, B., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9424582 · Cited by 85
Regulation of glutamate transporter trafficking by Nedd4-2 in a Parkinson’s disease model
Zhang, Y., He, X., Meng, X., Wu, X., Tong, H., Zhang, X., & Qu, S. (2017) · Cell Death and Disease · doi:10.1038/cddis.2016.454 · Cited by 95
Common Misconceptions About Lyme Disease
HALPERIN, J. J., Baker, P. J., & Wormser, G. P. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.10.008 · Cited by 94
Notable and Obvious Ketene Substituent-Dependent Effect of Temperature on the Stereoselectivity in the Staudinger Reaction
Li, B., Wang, Y., Du, D., & Xu, J. (2007) · The Journal of Organic Chemistry · doi:10.1021/jo0622734 · Cited by 94
Nuclear Factor- B Contributes to Neuron-Dependent Induction of Glutamate Transporter-1 Expression in Astrocytes
Ghosh, M., Yang, Y., Rothstein, J. D., & Robinson, M. B. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0302-11.2011 · Cited by 97
Self-citation
Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression
Li, Y., Sattler, R., Yang, E. J., Nunes, A., Ayukawa, Y., Akhtar, S., Ji, G., Zhang, P.-W., & Rothstein, J. D. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.10.016 · Cited by 93
Self-citation
Identification of Type 1 Inosine Monophosphate Dehydrogenase as an Antiangiogenic Drug Target
Chong, C. R., Qian, D. Z., Pan, F., Wei, Y., Пили, Р., Sullivan, D. J., & Liu, J. O. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051225t · Cited by 93
Targeting the Glutamatergic System for the Treatment of HIV-Associated Neurocognitive Disorders
Potter, M. C., Figuera-Losada, M., Rojas, C. J., & Slusher, B. S. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9442-z · Cited by 93
Increased glial glutamate transporter EAAT2 expression reduces epileptogenic processes following pilocarpine-induced status epilepticus
Kong, Q., Takahashi, K., Schulte, D. A., Stouffer, N., Lin, Y., & Lin, C. G. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.032 · Cited by 93
Novel glutamatergic agents for major depressive disorder and bipolar disorder
Machado-Vieira, R., Ibrahim, L., Henter, I. D., & Zarate, C. A. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.09.010 · Cited by 92
AEG-1/MTDH/LYRIC
Sarkar, D., & Fisher, P. B. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-401676-7.00002-4 · Cited by 91
Self-citation
Role of the Major Glutamate Transporter GLT1 in Nucleus Accumbens Core Versus Shell in Cue-Induced Cocaine-Seeking Behavior
Fischer, K. D., Houston, A. C. W., & Rebec, G. V. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3278-12.2013 · Cited by 94
GLT-1 transporter: An effective pharmacological target for various neurological disorders
Soni, N., Reddy, B. V. K., & Kumar, P. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.10.001 · Cited by 99
Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis
Corona, J. C., Tovar‐y‐Romo, L. B., & Tapia, R. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.11.1415 · Cited by 91
Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington’s disease: Interactions between neurons and astrocytes
Estrada‐Sánchez, A. M., & Rebec, G. V. (2012) · Basal Ganglia · doi:10.1016/j.baga.2012.04.029 · Cited by 92

Authors: Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., Toan, S. V., Bruijn, L. I., Su, Z.-Z., Gupta, P., & Fisher, P. B.
Affiliations: Johns Hopkins University (US)
Amyotrophic Lateral Sclerosis Association (US)
Columbia University Irving Medical Center (US)
Corresponding author: Rothstein, Jeffrey D.
ORCID: Rothstein, Jeffrey D.
Huang, Yanhua H.
Bergles, Dwight E.
Gupta, Pankaj
Fisher, Paul B.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2005-01
Volume: 433
Issue: 7021
Pages: 73-77
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature03180
OpenAlex: W2083204774
Cited by: 1,518
References: 27
Citations by year: 2026: 49 · 2025: 52 · 2024: 47 · 2023: 48 · 2022: 53 · 2021: 55 · 2020: 60 · 2019: 56 · 2018: 52 · 2017: 76 · 2016: 85 · 2015: 84 · 2014: 107 · 2013: 96 · 2012: 98
FWCI: 31.20
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Muscular Dystrophy Association
Johns Hopkins University
Robert Packard Center for ALS Research, Johns Hopkins University
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
Keywords: beta-lactam antibiotics, ceftriaxone, penicillin, GLT-1, glutamate transporters, neuroprotection, glutamate excitotoxicity, amyotrophic lateral sclerosis, ischemic brain injury, motor neuron degeneration, drug repurposing, transcriptional activation, astrocytes
MeSH terms: Animals, Anti-Bacterial Agents, Ceftriaxone, Cell Count, Cells, Cultured, Central Nervous System, Drug Evaluation, Preclinical, Gene Expression Regulation, Mice, Transgenic, Motor Neurons, Penicillins, Promoter Regions, Genetic, RNA, Messenger, United States, United States Food and Drug Administration, Transcriptional Activation, Genes, Reporter, Neuroprotective Agents, Ischemic Preconditioning, Excitatory Amino Acid Transporter 2, beta-Lactams, Mice, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks